Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients (Q30409595)

21 June 2017

Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients (English)

1 reference

ORCID Public Data File 2021

21 June 2017

0 references

1 reference

author name string

A Calmy

1

1 reference

21 June 2017

M Bel

2

1 reference

21 June 2017

A Nguyen

3

1 reference

21 June 2017

C Combescure

4

1 reference

21 June 2017

C Delhumeau

5

1 reference

21 June 2017

S Meier

6

1 reference

21 June 2017

S Yerly

7

1 reference

21 June 2017

L Kaiser

8

1 reference

21 June 2017

B Hirschel

9

1 reference

21 June 2017

C-A Siegrist

10

1 reference

21 June 2017

H1N1 Study Group

11

1 reference

21 June 2017

language of work or name

1 reference

7 November 2011

1 reference

21 June 2017

1 reference

21 June 2017

13

1 reference

21 June 2017

4

1 reference

21 June 2017

207-218

1 reference

Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection.

21 June 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Influenza A H1N1 in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Influenza vaccines for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Purification of Sendai Virions with Glutaraldehyde-Treated Red Blood Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

HIV-1 viraemia and influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Influenza, influenza virus vaccine, and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Comparison of the effects of acute influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Preexisting immunity to pandemic (H1N1) 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Pandemic influenza vaccine in adult HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00961.X

10.1111/J.1468-1293.2011.00961.X

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference